Tina Vilsbøll

Tina Vilsbøll

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology


  1. 2024
  2. E-pub ahead of print

    Expression of bile acid receptors and transporters along the intestine of patients with type 2 diabetes and controls

    Nerild, H. H., Gilliam-Vigh, H., Ellegaard, A., Forman, Julie Lyng, Vilsbøll, Tina, Sonne, David Peick, Brønden, Andreas & Knop, Filip Krag, 2024, (E-pub ahead of print) In: The Journal of clinical endocrinology and metabolism.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Elucidating the glucose-lowering effect of the bile acid sequestrant sevelamer

    Nerild, H. H., Brønden, A., Haddouchi, A. E., Ellegaard, A., Hartmann, Bolette, Rehfeld, Jens Frederik, Holst, Jens Juul, Sonne, David Peick, Vilsbøll, Tina & Knop, Filip Krag, 2024, In: Diabetes, Obesity and Metabolism. 26, 4, p. 1252-1263

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. E-pub ahead of print

    Liraglutide 3.0 mg once daily for the treatment of overweight and obesity in patients hospitalised at a forensic psychiatric department: A 26-week open-label feasibility study

    Sass, M. R., Christensen, A. M. B., Christensen, M. L., Gruber, E., Nerdrum, H., Pedersen, L. M., Resch, M., Jørgensen, T. H., Ekstrøm, Claus Thorn, Nielsen, Jimmi, Vilsbøll, Tina & Fink-Jensen, Anders, 2024, (E-pub ahead of print) In: Acta Psychiatrica Scandinavica.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    CVOT Summit Report 2023: new cardiovascular, kidney, and metabolic outcomes

    Schnell, O., Barnard-Kelly, K., Battelino, T., Ceriello, A., Larsson, H. E., Fernández-Fernández, B., Forst, T., Frias, J. P., Gavin, J. R., Giorgino, F., Groop, P. H., Heerspink, H. J. L., Herzig, S., Hummel, M., Huntley, G., Ibrahim, M., Itzhak, B., Jacob, S., Ji, L., Kosiborod, M. & 23 others, Lalic, N., Macieira, S., Malik, R. A., Mankovsky, B., Marx, N., Mathieu, C., Müller, T. D., Ray, K., Rodbard, H. W., Rossing, Peter, Rydén, L., Schumm-Draeger, P. M., Schwarz, P., Škrha, J., Snoek, F., Tacke, F., Taylor, B., Jeppesen, B. T., Tesfaye, S., Topsever, P., Vilsbøll, Tina, Yu, X. & Standl, E., 2024, In: Cardiovascular Diabetology. 23, 1, 17 p., 104.

    Research output: Contribution to journalComment/debateResearchpeer-review

  6. E-pub ahead of print

    Continuous Glucose Monitoring Profiles and Health Outcomes After Dapagliflozin Plus Saxagliptin vs Insulin Glargine

    Simonson, D. C., Testa, M. A., Ekholm, E., Su, M., Vilsbøll, Tina, Jabbour, S. A. & Lind, M., 2024, (E-pub ahead of print) In: The Journal of Clinical Endocrinology & Metabolism. p. 1-12

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    An Extended Minimal Model of OGTT: estimation of α- and β-cell dysfunction, insulin resistance, and the incretin effect

    Subramanian, V., Bagger, J. I., Harihar, V., Holst, Jens Juul, Knop, Filip Krag & Vilsbøll, Tina, 2024, In: American Journal of Physiology - Endocrinology and Metabolism. 326, 2, p. E182-E205

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. 2023
  9. Published

    Sustained heart rate-corrected QT prolongation during recovery from hypoglycaemia in people with type 1 diabetes, independently of recovery to hyperglycaemia or euglycaemia

    Andreasen, C. R., Andersen, A., Hagelqvist, P. G., Maytham, K., Lauritsen, J. V., Engberg, S., Faber, Jens, Pedersen-Bjergaard, Ulrik, Knop, Filip Krag & Vilsbøll, Tina, 2023, In: Diabetes, Obesity and Metabolism. 25, 6, p. 1566-1575 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    The future of incretins in the treatment of obesity and non-alcoholic fatty liver disease

    Andreasen, C. R., Andersen, A. & Vilsbøll, Tina, 2023, In: Diabetologia. 66, p. 1846-1858 13 p.

    Research output: Contribution to journalReviewResearchpeer-review

  11. Published

    Safety and tolerability of semaglutide across the SUSTAIN and PIONEER phase IIIa clinical trial programmes

    Aroda, V. R., Erhan, U., Jelnes, P., Meier, J. J., Abildlund, M. T., Pratley, R., Vilsbøll, Tina & Husain, M., 2023, In: Diabetes, Obesity and Metabolism. 25, 5, p. 1385-1397 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    Acarbose diminishes postprandial suppression of bone resorption in patients with type 2 diabetes

    Dalsgaard, N. B., Gasbjerg, Lærke Smidt, Helsted, M. M., Hansen, L. S., Hansen, N. L., Skov-Jeppesen, Kirsa, Hartmann, Bolette, Holst, Jens Juul, Vilsbøll, Tina & Knop, Filip Krag, 2023, In: Bone. 170, 116687.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...42 Next

ID: 33056950